Monroe Capital has acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the acquisition of ProPharma Group by private equity sponsor Linden Capital Partners.
Founded in 2001 and based in Overland Park, Kansas, ProPharma is a provider of outsourced medical information, pharmacovigilance, and regulatory compliance consulting services to customers in the pharmaceutical, biotechnology, and medical device industries.
The company has grown to a global organisation operating five contact centres across the US, Europe and Australia.
ProPharma serves a customer base which includes many of the world’s largest and well-known biopharmaceutical companies.
